Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 458 participants.

Also called NCT02702271

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 458 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02702271
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02702271. Non-randomized; no masking; primary purpose prevention. Start 2018-05-07 (actual); primary completion 2020-01-28 (actual). Results posted on 2022-06-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
Acronym
PINNACLE FLX
Intervention (Device)
WATCHMAN FLX
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct02702271
Content hash
c917bd1c5c3f0dfeb11e7f7f5ba8424d1551e8df5f43dc42c4aa1a1e4733bec3